A Noncoding RNA May Drive Alzheimer's Disease

July, 10 2008 8:32

Scientists have found a molecular mechanism that may drive the progression of Alzheimer's disease. The mechanism, involving the enzyme Beta secretase 1 (BACE1), is described online in Nature Medicine, and could become a target for future therapeutic efforts. Upon exposure to amyloid-beta, the molecule that results from the activity of BACE1 and that accumulates in the amyloid plaques characteristic of Alzheimer's disease, expression of the noncoding RNA is enhanced, which increases the levels of BACE1 and generates additional amyloid-beta through a positive feedback loop.

Author contact:

Claes Wahlestedt (The Scripps Research Institute, Jupiter, FL, USA)
E-mail: clawah@scripps.edu

Abstract available online.

(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News

Blood 'Fingerprints' For Cancer

Why The Brain Makes New Nerve Cells

Inherited Risk Factors For Common Leukemia

Telomerase Structure Revealed

Genetics Of Geography

Exploitative Tricks Of Antibiotic-Resistant Bacteria

Stem Cells Classified

Predisposition Gene For Childhood Cancer

A Potentially Dangerous Molecule On The Loose

Switching Fat To Lean

Venter Versus Watson

Moisturizers Increase Skin Cancer Risk In UV-Radiation Treated Mice

more news ...